SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Jun-24 5:37 PM View: | Blueprint Medicines Corp (BPMC) | 12-Jun-24 | Grant | 2,242 | -- | -- | 20% 11.01K to 13.25K | |
29-Feb-24 10:00 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-24 | Payment of Exercise | 61,371 | $2.62 | $160,792.00 | (5%) 1.16M to 1.1M | |
29-Feb-24 10:00 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-24 | Option Exercise | 245,080 | -- | -- | 27% 914.36K to 1.16M | |
17-Nov-23 4:55 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 16-Nov-23 | Private Purchase | 90,000 | $1.05 | $94,797.00 | 11% 824.36K to 914.36K | |
13-Nov-23 5:31 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 10-Nov-23 | Private Purchase | 10,000 | $1.01 | $10,100.00 | 1% 814.36K to 824.36K | |
29-Jun-23 4:13 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 29-Jun-23 | Private Purchase | 10,000 | $2.16 | $21,600.00 | 1% 804.36K to 814.36K | |
26-Jun-23 4:04 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 26-Jun-23 | Purchase | 10,000 | $2.18 | $21,792.00 | 1% 794.36K to 804.36K | |
26-Jun-23 4:04 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 23-Jun-23 | Private Purchase | 10,000 | $2.49 | $24,950.00 | 1% 784.36K to 794.36K | |
22-Jun-23 4:01 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 22-Jun-23 | Private Purchase | 40,000 | $2.31 | $92,400.00 | 5% 744.36K to 784.36K | |
23-Jun-23 7:04 PM View: | Blueprint Medicines Corp (BPMC) | 21-Jun-23 | Grant | 2,600 | -- | -- | 31% 8.41K to 11.01K | |
01-Mar-23 4:46 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-23 | Payment of Exercise | 50,971 | $2.17 | $110,607.00 | (6%) 795.33K to 744.36K | |
01-Mar-23 4:46 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-23 | Option Exercise | 209,327 | -- | -- | 36% 586.0K to 795.33K | |
30-Jun-22 9:57 PM View: | Blueprint Medicines Corp (BPMC) | 21-Jun-22 | Grant | 2,600 | -- | -- | 45% 5.81K to 8.41K | |
28-Feb-22 7:11 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-22 | Payment of Exercise | 48,053 | $2.85 | $136,951.00 | (8%) 634.06K to 586.0K | |
28-Feb-22 7:11 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-22 | Option Exercise | 197,343 | -- | -- | 45% 436.71K to 634.06K | |
04-Jun-21 4:19 PM View: | Blueprint Medicines Corp (BPMC) | 02-Jun-21 | Grant | 2,250 | -- | -- | 63% 3.56K to 5.81K | |
02-Mar-21 4:57 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-21 | Payment of Exercise | 55,038 | $7.19 | $395,723.00 | (11%) 491.75K to 436.71K | |
02-Mar-21 4:57 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-21 | Option Exercise | 192,885 | -- | -- | 65% 298.87K to 491.75K | |
26-Jun-20 4:11 PM View: | Blueprint Medicines Corp (BPMC) | 24-Jun-20 | Grant | 2,250 | -- | -- | 171% 1.31K to 3.56K | |
23-Jun-20 4:19 PM View: | Blueprint Medicines Corp (BPMC) | 19-Jun-20 | Option Exercise | 1,312 | -- | -- | 100% 0 to 1.31K | |
03-Mar-20 4:11 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-20 | Payment of Exercise | 45,320 | $2.77 | $125,536.00 | (13%) 344.19K to 298.87K | (26%) |
03-Mar-20 4:11 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-20 | Option Exercise | 116,647 | -- | -- | 51% 227.54K to 344.19K | |
19-Sep-19 4:28 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 18-Sep-19 | Market Purchase | 50,000 | $3.10 | $155,000.00 | 28% 177.54K to 227.54K | 13% |
18-Sep-19 4:39 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 17-Sep-19 | Market Purchase | 50,000 | $3.13 | $156,403.00 | 39% 127.54K to 177.54K | 12% |
20-Aug-19 5:02 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 19-Aug-19 | Market Purchase | 3,000 | $1.40 | $4,194.00 | 2% 124.54K to 127.54K | 149% |
20-Aug-19 5:02 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 16-Aug-19 | Market Purchase | 37,000 | $1.35 | $49,834.70 | 42% 87.54K to 124.54K | 159% |
19-Aug-19 4:34 PM View: | Blueprint Medicines Corp (BPMC) | 15-Aug-19 | Option Exercise | 10,000 | $15.01 | $150,100.00 | 100% 0 to 10.0K | |
19-Aug-19 4:34 PM View: | Blueprint Medicines Corp (BPMC) | 15-Aug-19 | Market Option Sale | 10,000 | $82.40 | $824,007.00 | (100%) 10.0K to 0 | (17%) |
01-Mar-19 5:15 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-19 | Payment of Exercise | 18,641 | $5.51 | $102,712.00 | (18%) 106.18K to 87.54K | 37% |
01-Mar-19 5:15 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-19 | Option Exercise | 48,101 | -- | -- | 83% 58.08K to 106.18K | |
02-Mar-18 5:07 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-18 | Payment of Exercise | 9,494 | $8.53 | $80,983.80 | (14%) 67.57K to 58.08K | 59% |
02-Mar-18 5:07 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-18 | Option Exercise | 24,588 | -- | -- | 57% 42.98K to 67.57K | |
15-Nov-17 5:15 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 15-Nov-17 | Market Purchase | 10,000 | $9.91 | $99,100.00 | 30% 32.98K to 42.98K | (65%) |
18-Sep-17 6:40 AM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 15-Sep-17 | Market Purchase | 30,000 | $12.54 | $376,337.00 | 1005% 2.98K to 32.98K | (72%) |
01-Mar-17 6:48 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-17 | Payment of Exercise | 5,258 | $16.45 | $86,494.10 | (20%) 26.02K to 20.77K | 79% |
01-Mar-17 6:48 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Feb-17 | Option Exercise | 19,226 | -- | -- | 283% 6.8K to 26.02K | |
02-Mar-16 8:44 AM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 29-Feb-16 | Payment of Exercise | 4,036 | $9.07 | $36,606.50 | (37%) 10.84K to 6.8K | 62% |
02-Mar-16 8:44 AM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 29-Feb-16 | Option Exercise | 10,835 | -- | -- | 100% 0 to 10.84K |